| # | Side effect | Count |
|---|---|---|
| 0 | FATIGUE | 169 |
| 1 | OFF LABEL USE | 155 |
| 2 | VISUAL IMPAIRMENT | 145 |
| 3 | HAEMOGLOBIN DECREASED | 129 |
| 4 | VITREOUS FLOATERS | 116 |
| 5 | HAEMOLYSIS | 109 |
| 6 | BREAKTHROUGH HAEMOLYSIS | 96 |
| 7 | HEADACHE | 92 |
| 8 | UVEITIS | 80 |
| 9 | PRODUCT DOSE OMISSION ISSUE | 75 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | CSF SHUNT CONVERSION | 1 | 1.0000 |
| 1 | ANTERIOR SEGMENT NEOVASCULARISATION | 8 | 0.6667 |
| 2 | INJECTION SITE FOREIGN BODY SENSATION IN EYE | 2 | 0.5000 |
| 3 | COMPLEMENT SPLIT PRODUCTS INCREASED | 2 | 0.5000 |
| 4 | FLUORESCENCE ANGIOGRAM ABNORMAL | 5 | 0.4545 |
| 5 | AQUEOUS MISDIRECTION | 1 | 0.3333 |
| 6 | BODY FLUID ANALYSIS | 1 | 0.2500 |
| 7 | BREAKTHROUGH HAEMOLYSIS | 96 | 0.2406 |
| 8 | HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS | 16 | 0.2192 |
| 9 | ORAL PURPURA | 2 | 0.1818 |